缩写名/全名 |
PHARMACOL THERAPEUT
PHARMACOLOGY & THERAPEUTICS |
||||||||||||||||||||
ISSN号 | 0163-7258 | ||||||||||||||||||||
研究方向 | 医学-药学 | ||||||||||||||||||||
影响因子 | 2015:11, 2016:11.127, 2017:10.376, 2018:9.396, 2019:10.557, | ||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||
年文章数 | 148 | ||||||||||||||||||||
出版年份 | 1979 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 偏慢,4-8周 来源Elsevier官网:平均15.8周 |
||||||||||||||||||||
录用比例 | 较难 | ||||||||||||||||||||
投稿链接 | http://www.elsevier.com/ | ||||||||||||||||||||
投稿官网 | http://www.journals.elsevier.com/pharmacology-and-therapeutics/ | ||||||||||||||||||||
h-index | 180 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0163-7258%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities Author: Piao Huang, Rong Yan, Xue Zhang, Lei Wang, Xisong Ke, Yi Qu Journal: PHARMACOLOGY & THERAPEUTICS, 2018, Vol., , DOI:10.1016/j.pharmthera.2018.11.008 DOI |
2. | Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies Author: Yu Chen, Amy K.Y. Fu, Nancy Y. Ip Journal: PHARMACOLOGY & THERAPEUTICS, 2018, Vol., , DOI:10.1016/j.pharmthera.2018.11.006 DOI |
3. | The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy Author: Xiangjin Zheng, Wan Li, Liwen Ren, Jinyi Liu, Xiaocong Pang, Xiuping Chen, De Kang, Jinhua Wang, Guanhua Du Journal: PHARMACOLOGY & THERAPEUTICS, 2018, Vol., , DOI:10.1016/j.pharmthera.2018.10.011 DOI |
4. | P53 in kidney injury and repair: Mechanism and therapeutic potentials Author: Chengyuan Tang, Zhengwei Ma, Jiefu Zhu, Zhiwen Liu, Yuxue Liu, Yu Liu, Juan Cai, Zheng Dong Journal: PHARMACOLOGY & THERAPEUTICS, 2018, Vol., , DOI:10.1016/j.pharmthera.2018.10.013 DOI |
5. | Statins: Adverse reactions, oxidative stress and metabolic interactions Author: Aimei Liu, Qinghua Wu, Jingchao Guo, Irma Ares, José-Luis Rodríguez, María-Rosa Martínez-Larrañaga, Zonghui Yuan, Arturo Anadón, Xu Wang, María-Aránzazu Martínez Journal: PHARMACOLOGY & THERAPEUTICS, 2018, Vol., , DOI:10.1016/j.pharmthera.2018.10.004 DOI |
6. | Effects and mechanisms of compound Chinese medicine and major ingredients on microcirculatory dysfunction and organ injury induced by ischemia/reperfusion Author: Jing-Yan Han, Quan Li, Zhi-Zhong Ma, Jing-Yu Fan Journal: PHARMACOLOGY & THERAPEUTICS, 2017, Vol.177, 146-173, DOI:10.1016/j.pharmthera.2017.03.005 DOI |
7. | The roles of histamine and its receptor ligands in central nervous system disorders: An update Author: Weiwei Hu, Zhong Chen Journal: PHARMACOLOGY & THERAPEUTICS, 2017, Vol.175, 116-132, DOI:10.1016/j.pharmthera.2017.02.039 DOI |
8. | Experimental animal modeling for immuno-oncology Author: Qi-Xiang Li, Gerold Feuer, Xuesong Ouyang, Xiaoyu An Journal: PHARMACOLOGY & THERAPEUTICS, 2017, Vol.173, 34-46, DOI:10.1016/j.pharmthera.2017.02.002 DOI |
9. | The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance Author: Guan-Zhong Qiu, Wei Sun, Ming-Zhu Jin, Jing Lin, Pei-Gang Lu, Wei-Lin Jin Journal: PHARMACOLOGY & THERAPEUTICS, 2017, Vol.172, 127-138, DOI:10.1016/j.pharmthera.2016.12.003 DOI |
10. | Toll-like receptors mediating vascular malfunction: Lessons from receptor subtypes. Author: Wang Y, Song E, Bai B, Vanhoutte PM. Journal: Pharmacol Ther. 2016 Feb;158:91-100. doi: 10.1016/j.pharmthera.2015.12.005. Epub 2015 Dec 15. Review. PubMed |
|
|